128 related articles for article (PubMed ID: 29038761)
21. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
22. Assessment of clinical performance of an ultrasensitive nanowire assay for detecting human papillomavirus DNA in urine.
Lee H; Choi M; Jo M; Park EY; Hwang SH; Cho Y
Gynecol Oncol; 2020 Mar; 156(3):641-646. PubMed ID: 31926639
[TBL] [Abstract][Full Text] [Related]
23. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the Abbott RealTime High Risk HPV test and the Roche cobas 4800 HPV test using urine samples.
Lim MC; Lee DH; Hwang SH; Hwang NR; Lee B; Shin HY; Jun JK; Yoo CW; Lee DO; Seo SS; Park SY; Joo J
J Virol Methods; 2017 May; 243():74-79. PubMed ID: 28161277
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of reflex HPV16/18 genotyping in predicting CIN3/VAIN3 in women with HPV+/Pap- results.
Guo M; Khanna A; Dawlett M; Patel S; Gong Y; Staerkel G
J Am Soc Cytopathol; 2016; 5(1):31-36. PubMed ID: 31042536
[TBL] [Abstract][Full Text] [Related]
26. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Intaraphet S; Siriaunkgul S
J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
[TBL] [Abstract][Full Text] [Related]
27. The ideal strategy for cervical cancer screening in Japan: Result from the Fukui Cervical Cancer Screening Study.
Kurokawa T; Onuma T; Shinagawa A; Chino Y; Kobayashi M; Yoshida Y
Cytopathology; 2018 Aug; 29(4):361-367. PubMed ID: 29768678
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Urine and Genital Samples for Detecting Human Papillomavirus (HPV) in Clinical Patients.
Yang H; Luo ZY; Lin F; Li LJ; Lu M; Xie LX; Yang LY
Obstet Gynecol Int; 2023; 2023():7483783. PubMed ID: 37020494
[TBL] [Abstract][Full Text] [Related]
29. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
Othman N; Othman NH
Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
[TBL] [Abstract][Full Text] [Related]
30. Detection of human papillomavirus in urine and cervical swabs from patients with invasive cervical cancer.
Stanczuk GA; Kay P; Allan B; Chirara M; Tswana SA; Bergstrom S; Sibanda EN; Williamson AL
J Med Virol; 2003 Sep; 71(1):110-4. PubMed ID: 12858416
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the Cepheid Xpert HPV test and the HC2 High-Risk HPV DNA Test for detection of high-risk HPV infection in cervical smear samples in SurePath preservative fluid.
Rabaan AA; Alfaraj SA; Alkhalifah MA
J Med Microbiol; 2018 May; 67(5):676-680. PubMed ID: 29580367
[No Abstract] [Full Text] [Related]
32. The evaluation of human papillomavirus genotyping in cervical liquid-based cytology specimens; using the Roche Linear Array HPV genotyping assay.
Jamison J; Wilson RT; Carson J
Cytopathology; 2009 Aug; 20(4):242-8. PubMed ID: 19291176
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
[TBL] [Abstract][Full Text] [Related]
34. Cervical cancer screening by cytology and human papillomavirus testing during pregnancy in French women with poor adhesion to regular cervical screening.
Brun-Micaleff E; Coffy A; Rey V; Didelot MN; Combecal J; Doutre S; Daurès JP; Segondy M; Boulle N
J Med Virol; 2014 Mar; 86(3):536-45. PubMed ID: 24114972
[TBL] [Abstract][Full Text] [Related]
35. Comparison Between Two Detection Methods for HPV16, HPV18 and P16Ink4a Biomarkers in Diagnosis of Abnormal Cervical Cytology.
Khazaei S; Izadi B; Mirbahari SG; Madani SH; Malek Khosravi Sh; Emami Alagha M; Sajadimajd S
Asian Pac J Cancer Prev; 2016 Dec; 17(12):5223-5227. PubMed ID: 28125865
[TBL] [Abstract][Full Text] [Related]
36. Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe.
Dube Mandishora RS; Christiansen IK; Chin'ombe N; Duri K; Ngara B; Rounge TB; Meisal R; Ambur OH; Palefsky JM; Stray-Pedersen B; Chirenje ZM
J Med Virol; 2017 Sep; 89(9):1671-1677. PubMed ID: 28390142
[TBL] [Abstract][Full Text] [Related]
37. Analysis of HR-HPV Infection Concordance Rates in Cervical and Urine Specimens; Proposal of Additional Cervical Screening Process for Women Who Refuse Invasive Cervical Sampling.
Kim DH; Jin H; Lee KE
J Pers Med; 2022 Nov; 12(12):. PubMed ID: 36556170
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Hybribio GenoArray and Roche human papillomavirus (HPV) linear array for HPV genotyping in anal swab samples.
Low HC; Silver MI; Brown BJ; Leng CY; Blas MM; Gravitt PE; Woo YL
J Clin Microbiol; 2015 Feb; 53(2):550-6. PubMed ID: 25502520
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.
Xu L; Oštrbenk A; Poljak M; Arbyn M
J Clin Virol; 2018 Jan; 98():37-42. PubMed ID: 29241150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
